Publications – 2012

  • Elmariah S, Arzamendi D, Palacios IF. Balloon Aortic Valvuloplasty in the Transcatheter Aortic Valve Replacement Era. Interv Cardiol Clin. 2012 Jan;1(1):129-137. doi: 10.1016/j.iccl.2011.11.001. Epub 2011 Dec 16.
  • Chakrabarti AK, Patel SJ, Salazar RL, Gopalakrishnan L, Kumar V, Rastogi U, Singh P, Zorkun C, Gibson CM. Newer Pharmaceutical Agents for STEMI Interventions. Interv Cardiol Clin. 2012 Oct;1(4):429-440. doi: 10.1016/j.iccl.2012.06.005. Epub 2012 Sep 1.
  • Ellis ER, Reynolds MR. Body Mass Index, Quality of Life, and Catheter Ablation in Patients with Atrial Fibrillation. J Atr Fibrillation. 2012 Dec 16;5(4):426. doi: 10.4022/jafib.426. eCollection 2012 Dec.
  • Chakrabarti AK, Patel SJ, Kohli P, Udell JA, Singh P, Gopalakrishnan L, Kumar V, Gibson CM. Cost-Effective Medicines for Stroke Prophylaxis in Patients with Atrial Fibrillation. J Atr Fibrillation. 2012 Jun 15;5(1):470. doi: 10.4022/jafib.470. eCollection 2012 Jun-Jul.
  • Kalish J, Nguyen T, Hamburg N, Eberhardt R, Rybin D, Doros G, Farber A. Associated venous injury significantly complicates presentation, management, and outcomes of axillosubclavian arterial trauma. Int J Angiol. 2012 Dec;21(4):217-22. doi: 10.1055/s-0032-1330969.
  • Meisel SR, Januzzi JL, Medvedovski M, Sharist M, Shochat M, Ashkar J, Peschansky P, Haim SB, Blondheim DS, Glikson M, Shotan A. Pre-admission NT-proBNP improves diagnostic yield and risk stratification – the NT-proBNP for EValuation of dyspnoeic patients in the Emergency Room and hospital (BNP4EVER) study. Eur Heart J Acute Cardiovasc Care. 2012 Jun;1(2):99-108. doi: 10.1177/2048872612447049.
  • Breydo E, Shubina M, Shalaby JW, Einbinder JS, Turchin A. Lexical concept distribution reflects clinical practice. AMIA Annu Symp Proc. 2012;2012:61-6. Epub 2012 Nov 3.
  • Mills KC, Kwatra SG, Feneran AN, Pearce DJ, Williford PM, D’Agostino RB, Yosipovitch G. Itch and pain in nonmelanoma skin cancer: pain as an important feature of cutaneous squamous cell carcinoma. Arch Dermatol. 2012 Dec;148(12):1422-3. doi: 10.1001/archdermatol.2012.3104.
  • Reynolds MR, Turek JJ. A dynamic developmental link between verbal comprehension-knowledge (Gc) and reading comprehension: verbal comprehension-knowledge drives positive change in reading comprehension. J Sch Psychol. 2012 Dec;50(6):841-63. doi: 10.1016/j.jsp.2012.07.002. Epub 2012 Aug 11.
  • Margheri G, D’Agostino R, Becucci L, Guidelli R, Tiribilli B, Del Rosso M. Surface plasmon resonance as detection tool for lipids lateral mobility in biomimetic membranes. Biomed Opt Express. 2012 Dec 1;3(12):3119-26. doi: 10.1364/BOE.3.003119. Epub 2012 Nov 6.
  • Kohli P, Cannon CP. The importance of matching language to type of evidence: avoiding the pitfalls of reporting outcomes data. Clin Cardiol. 2012 Dec;35(12):714-7. doi: 10.1002/clc.22066. Epub 2012 Nov 28.
  • Cutlip DE, Pinto DS. Extracranial carotid disease revascularization. Circulation. 2012 Nov 27;126(22):2636-44. doi: 10.1161/CIRCULATIONAHA.112.110411.
  • Torina A, Agnone A, Blanda V, Alongi A, D’Agostino R, Caracappa S, Marino AM, Di Marco V, de la Fuente J. Development and validation of two PCR tests for the detection of and differentiation between Anaplasma ovis and Anaplasma marginale. Ticks Tick Borne Dis. 2012 Dec;3(5-6):283-7. doi: 10.1016/j.ttbdis.2012.10.033. Epub 2012 Nov 20.
  • Rogers JH, Goldstein I, Kandzari DE, Köhler TS, Stinis CT, Wagner PJ, Popma JJ, Jaff MR, Rocha-Singh KJ. Zotarolimus-eluting peripheral stents for the treatment of erectile dysfunction in subjects with suboptimal response to phosphodiesterase-5 inhibitors. J Am Coll Cardiol. 2012 Dec 25;60(25):2618-27. doi: 10.1016/j.jacc.2012.08.1016. Epub 2012 Nov 21.
  • Tsai SB, Seldin DC, Quillen K, Berk JL, Ruberg FL, Meier-Ewert H, Sloan JM, Doros G, Finn KT, Skinner M, Sanchorawala V. High-dose melphalan and stem cell transplantation for patients with AL amyloidosis: trends in treatment-related mortality over the past 17 years at a single referral center. Blood. 2012 Nov 22;120(22):4445-6. doi: 10.1182/blood-2012-09-457341.
  • Kato K, Yonetsu T, Kim SJ, Xing L, Lee H, McNulty I, Yeh RW, Sakhuja R, Zhang S, Uemura S, Yu B, Mizuno K, Jang IK. Comparison of nonculprit coronary plaque characteristics between patients with and without diabetes: a 3-vessel optical coherence tomography study. JACC Cardiovasc Interv. 2012 Nov;5(11):1150-8. doi: 10.1016/j.jcin.2012.06.019.
  • Hill MD, Brooks W, Mackey A, Clark WM, Meschia JF, Morrish WF, Mohr JP, Rhodes JD, Popma JJ, Lal BK, Longbottom ME, Voeks JH, Howard G, Brott TG; CREST Investigators. Stroke after carotid stenting and endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Circulation. 2012 Dec 18;126(25):3054-61. doi: 10.1161/CIRCULATIONAHA.112.120030. Epub 2012 Nov 16.
  • Prendergast BD, Naber CK, Popma JJ. Transatlantic perspectives on TAVI: from essential infrastructure and integration to expansion, research and development. Heart. 2012 Nov;98 Suppl 4:iv37-43. doi: 10.1136/heartjnl-2012-302397.
  • Bhardwaj A, Rehman SU, Mohammed AA, Gaggin HK, Barajas L, Barajas J, Moore SA, Sullivan D, Januzzi JL. Quality of life and chronic heart failure therapy guided by natriuretic peptides: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study. Am Heart J. 2012 Nov;164(5):793-799.e1. doi: 10.1016/j.ahj.2012.08.015.
  • Mogabgab O, Giugliano RP, Sabatine MS, Cannon CP, Mohanavelu S, Wiviott SD, Antman EM, Braunwald E. Circadian variation in patient characteristics and outcomes in ST-segment elevation myocardial infarction. Chronobiol Int. 2012 Dec;29(10):1390-6. doi: 10.3109/07420528.2012.728658. Epub 2012 Nov 6.
  • Boyer NM, Laskey WK, Cox M, Hernandez AF, Peterson ED, Bhatt DL, Cannon CP, Fonarow GC. Trends in clinical, demographic, and biochemical characteristics of patients with acute myocardial infarction from 2003 to 2008: a report from the american heart association get with the guidelines coronary artery disease program. J Am Heart Assoc. 2012 Aug;1(4):e001206. doi: 10.1161/JAHA.112.001206. Epub 2012 Aug 24.
  • Wimmer NJ, Yeh RW, Cutlip DE, Mauri L. Risk prediction for adverse events after carotid artery stenting in higher surgical risk patients. Stroke. 2012 Dec;43(12):3218-24. doi: 10.1161/STROKEAHA.112.673194. Epub 2012 Nov 5.
  • Reynolds MR, Magnuson EA, Lei Y, Wang K, Vilain K, Li H, Walczak J, Pinto DS, Thourani VH, Svensson LG, Mack MJ, Miller DC, Satler LE, Bavaria J, Smith CR, Leon MB, Cohen DJ; PARTNER Investigators. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol. 2012 Dec 25;60(25):2683-92. doi: 10.1016/j.jacc.2012.09.018. Epub 2012 Nov 1.
  • Parikh NI, Honeycutt EF, Roe MT, Neely M, Rosenthal EJ, Mittleman MA, Carrozza JP Jr, Ho KK. Left and codominant coronary artery circulations are associated with higher in-hospital mortality among patients undergoing percutaneous coronary intervention for acute coronary syndromes: report From the National Cardiovascular Database Cath Percutaneous Coronary Intervention (CathPCI) Registry. Circ Cardiovasc Qual Outcomes. 2012 Nov;5(6):775-82. doi: 10.1161/CIRCOUTCOMES.111.964593. Epub 2012 Oct 30.
  • Stolker JM, Cohen DJ, Kennedy KF, Pencina MJ, Lindsey JB, Mauri L, Cutlip DE, Kleiman NS; Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) Investigators. Repeat revascularization after contemporary percutaneous coronary intervention: an evaluation of staged, target lesion, and other unplanned revascularization procedures during the first year. Circ Cardiovasc Interv. 2012 Dec;5(6):772-82. doi: 10.1161/CIRCINTERVENTIONS.111.967802. Epub 2012 Oct 23.
  • Vassilev D, Gil RJ, Koo BK, Gibson CM, Nguyen T, Hoang T, Gotcheva N. The determinants of side branch compromise after main vessel stenting in coronary bifurcation lesions. Kardiol Pol. 2012;70(10):989-97.
  • Coglianese EE, Larson MG, Vasan RS, Ho JE, Ghorbani A, McCabe EL, Cheng S, Fradley MG, Kretschman D, Gao W, O’Connor G, Wang TJ, Januzzi JL. Distribution and clinical correlates of the interleukin receptor family member soluble ST2 in the Framingham Heart Study. Clin Chem. 2012 Dec;58(12):1673-81. doi: 10.1373/clinchem.2012.192153. Epub 2012 Oct 11.
  • Jensen JK, Ueland T, Aukrust P, Antonsen L, Kristensen SR, Januzzi JL, Ravkilde J. Highly sensitive troponin T in patients with acute ischemic stroke. Eur Neurol. 2012;68(5):287-93. doi: 10.1159/000341340. Epub 2012 Oct 5.
  • Novack V, Cohen DJ, Cutlip DE. Misconstrued intentions: setting the record straight. Arch Intern Med. 2012 Oct 8;172(18):1425-6; author reply 1426-7. doi: 10.1001/archinternmed.2012.3752.
  • Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol. 2012 Oct 9;60(15):1438-54. doi: 10.1016/j.jacc.2012.09.001.
  • Little RJ, D’Agostino R, Cohen ML, Dickersin K, Emerson SS, Farrar JT, Frangakis C, Hogan JW, Molenberghs G, Murphy SA, Neaton JD, Rotnitzky A, Scharfstein D, Shih WJ, Siegel JP, Stern H. The prevention and treatment of missing data in clinical trials. N Engl J Med. 2012 Oct 4;367(14):1355-60. doi: 10.1056/NEJMsr1203730.
  • Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P, Walker M, Thompson A, Sarwar N, Caslake M, Butterworth AS, Amouyel P, Assmann G, Bakker SJ, Barr EL, Barrett-Connor E, Benjamin EJ, Björkelund C, Brenner H, Brunner E, Clarke R, Cooper JA, Cremer P, Cushman M, Dagenais GR, D’Agostino RB Sr, Dankner R, Davey-Smith G, Deeg D, Dekker JM, Engström G, Folsom AR, Fowkes FG, Gallacher J, Gaziano JM, Giampaoli S, Gillum RF, Hofman A, Howard BV, Ingelsson E, Iso H, Jørgensen T, Kiechl S, Kitamura A, Kiyohara Y, Koenig W, Kromhout D, Kuller LH, Lawlor DA, Meade TW, Nissinen A, Nordestgaard BG, Onat A, Panagiotakos DB, Psaty BM, Rodriguez B, Rosengren A, Salomaa V, Kauhanen J, Salonen JT, Shaffer JA, Shea S, Ford I, Stehouwer CD, Strandberg TE, Tipping RW, Tosetto A, Wassertheil-Smoller S, Wennberg P, Westendorp RG, Whincup PH, Wilhelmsen L, Woodward M, Lowe GD, Wareham NJ, Khaw KT, Sattar N, Packard CJ, Gudnason V, Ridker PM, Pepys MB, Thompson SG, Danesh J. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012 Oct 4;367(14):1310-20. doi: 10.1056/NEJMoa1107477.
  • Chakrabarti AK, Gibson CM, Pinto DS. Optimal selection of STEMI treatment strategies in the current era: benefit of transferring STEMI patients for PCI compared with administration of onsite fibrinolytic therapy. Curr Opin Cardiol. 2012 Nov;27(6):651-4. doi: 10.1097/HCO.0b013e3283587c69.
  • Bangalore S, Steg G, Deedwania P, Crowley K, Eagle KA, Goto S, Ohman EM, Cannon CP, Smith SC, Zeymer U, Hoffman EB, Messerli FH, Bhatt DL; REACH Registry Investigators. β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA. 2012 Oct 3;308(13):1340-9. doi: 10.1001/jama.2012.12559.
  • Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB; Valve Academic Research Consortium (VARC)-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2). Eur J Cardiothorac Surg. 2012 Nov;42(5):S45-60. doi: 10.1093/ejcts/ezs533. Epub 2012 Oct 1.
  • Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J. 2012 Oct;33(19):2403-18. doi: 10.1093/eurheartj/ehs255.
  • Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, Brott TG, Cohen DJ, Cutlip DE, van Es GA, Hahn RT, Kirtane AJ, Krucoff MW, Kodali S, Mack MJ, Mehran R, Rodés-Cabau J, Vranckx P, Webb JG, Windecker S, Serruys PW, Leon MB; Valve Academic Research Consortium-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. EuroIntervention. 2012 Nov 22;8(7):782-95. doi: 10.4244/EIJV8I7A121.
  • Varenhorst C, Alström U, Scirica BM, Hogue CW, Åsenblad N, Storey RF, Steg PG, Horrow J, Mahaffey KW, Becker RC, James S, Cannon CP, Brandrup-Wognsen G, Wallentin L, Held C. Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery. J Am Coll Cardiol. 2012 Oct 23;60(17):1623-30. doi: 10.1016/j.jacc.2012.07.021. Epub 2012 Sep 26.
  • Hawkins BM, Kennedy KF, Giri J, Saltzman AJ, Rosenfield K, Drachman DE, White CJ, Spertus JA, Yeh RW. Pre-procedural risk quantification for carotid stenting using the CAS score: a report from the NCDR CARE Registry. J Am Coll Cardiol. 2012 Oct 23;60(17):1617-22. doi: 10.1016/j.jacc.2012.07.026. Epub 2012 Sep 19.
  • Messenger JC, Ho KK, Young CH, Slattery LE, Draoui JC, Curtis JP, Dehmer GJ, Grover FL, Mirro MJ, Reynolds MR, Rokos IC, Spertus JA, Wang TY, Winston SA, Rumsfeld JS, Masoudi FA; NCDR Science and Quality Oversight Committee Data Quality Workgroup. The National Cardiovascular Data Registry (NCDR) Data Quality Brief: the NCDR Data Quality Program in 2012. J Am Coll Cardiol. 2012 Oct 16;60(16):1484-8. doi: 10.1016/j.jacc.2012.07.020. Epub 2012 Sep 19.
  • Ho JE, Mahajan A, Chen MH, Larson MG, McCabe EL, Ghorbani A, Cheng S, Johnson AD, Lindgren CM, Kempf T, Lind L, Ingelsson E, Vasan RS, Januzzi J, Wollert KC, Morris AP, Wang TJ. Clinical and genetic correlates of growth differentiation factor 15 in the community. Clin Chem. 2012 Nov;58(11):1582-91. doi: 10.1373/clinchem.2012.190322. Epub 2012 Sep 20.
  • Pride YB, Mohanavelu S, Zorkun C, Kunadian V, Giugliano RP, Newby LK, Braunwald E, Califf RM, Harrington RA, Gibson CM; EARLY ACS Investigators. Association between angiographic complications and clinical outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention: an EARLY ACS (Early Glycoprotein IIb/IIIa Inhibition in Non-ST-Segment Elevation Acute Coronary Syndrome) angiographic substudy. JACC Cardiovasc Interv. 2012 Sep;5(9):927-35. doi: 10.1016/j.jcin.2012.05.007.
  • Husted S, James S, Becker RC, Horrow J, Katus H, Storey RF, Cannon CP, Heras M, Lopes RD, Morais J, Mahaffey KW, Bach RG, Wojdyla D, Wallentin L; PLATO study group. Ticagrelor versus clopidogrel in elderly patients with acute coronary syndromes: a substudy from the prospective randomized PLATelet inhibition and patient Outcomes (PLATO) trial. Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):680-8. doi: 10.1161/CIRCOUTCOMES.111.964395.
  • Pettitt DJ, Talton JW, Liese AD, Liu LL, Crimmins N, West NA, D’ Agostino RB Jr, Kahn HS; SEARCH for Diabetes in Youth Study Group. Comparison of two waist circumference measurement protocols: the SEARCH for diabetes in youth study. Pediatr Obes. 2012 Dec;7(6):e81-5. doi: 10.1111/j.2047-6310.2012.00088.x. Epub 2012 Sep 19.
  • Dabelea D, Mayer-Davis EJ, Andrews JS, Dolan LM, Pihoker C, Hamman RF, Greenbaum C, Marcovina S, Fujimoto W, Linder B, Imperatore G, D’Agostino R Jr. Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study. Diabetologia. 2012 Dec;55(12):3359-68. doi: 10.1007/s00125-012-2719-6. Epub 2012 Sep 20.
  • Siebert U, Alagoz O, Bayoumi AM, Jahn B, Owens DK, Cohen DJ, Kuntz KM. State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3. Med Decis Making. 2012 Sep-Oct;32(5):690-700. doi: 10.1177/0272989X12455463.
  • Matyal R, Chu L, Mahmood F, Robich MP, Wang A, Hess PE, Shahul S, Pinto DS, Khabbaz K, Sellke FW. Neuropeptide Y improves myocardial perfusion and function in a swine model of hypercholesterolemia and chronic myocardial ischemia. J Mol Cell Cardiol. 2012 Dec;53(6):891-8. doi: 10.1016/j.yjmcc.2012.08.027. Epub 2012 Sep 12.
  • Lopes RD, Williams JB, Mehta RH, Reyes EM, Hafley GE, Allen KB, Mack MJ, Peterson ED, Harrington RA, Gibson CM, Califf RM, Kouchoukos NT, Ferguson TB, Lorenz TJ, Alexander JH. Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results. Am Heart J. 2012 Sep;164(3):379-386.e1. doi: 10.1016/j.ahj.2012.05.019.
  • Rosenberg MA, Patton KK, Sotoodehnia N, Karas MG, Kizer JR, Zimetbaum PJ, Chang JD, Siscovick D, Gottdiener JS, Kronmal RA, Heckbert SR, Mukamal KJ. The impact of height on the risk of atrial fibrillation: the Cardiovascular Health Study. Eur Heart J. 2012 Nov;33(21):2709-17. doi: 10.1093/eurheartj/ehs301. Epub 2012 Sep 12.
  • Harris KM, Braverman AC, Eagle KA, Woznicki EM, Pyeritz RE, Myrmel T, Peterson MD, Voehringer M, Fattori R, Januzzi JL, Gilon D, Montgomery DG, Nienaber CA, Trimarchi S, Isselbacher EM, Evangelista A. Acute aortic intramural hematoma: an analysis from the International Registry of Acute Aortic Dissection. Circulation. 2012 Sep 11;126(11 Suppl 1):S91-6. doi: 10.1161/CIRCULATIONAHA.111.084541.
  • Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Joint ESC/ACCF/AHA/WHF Task Force for Universal Definition of Myocardial Infarction; Authors/Task Force Members Chairpersons, Thygesen K, Alpert JS, White HD; Biomarker Subcommittee, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA; ECG Subcommittee, Chaitman BR, Clemmensen PM, Johanson P, Hod H; Imaging Subcommittee, Underwood R, Bax JJ, Bonow JJ, Pinto F, Gibbons RJ; Classification Subcommittee, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW; Intervention Subcommittee, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasche P, Ravkilde J; Trials & Registries Subcommittee, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML; Trials & Registries Subcommittee, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G; Trials & Registries Subcommittee, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D; Trials & Registries Subcommittee, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S; ESC Committee for Practice Guidelines (CPG), Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S; Document Reviewers, Morais J, Aguiar C, Almahmeed W, Arnar DO, Barili F, Bloch KD, Bolger AF, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98. doi: 10.1016/j.jacc.2012.08.001. Epub 2012 Sep 5.
  • Elmariah S, Fifer MA. Medical, surgical and interventional management of hypertrophic cardiomyopathy with obstruction. Curr Treat Options Cardiovasc Med. 2012 Dec;14(6):665-78. doi: 10.1007/s11936-012-0206-5.
  • Somma KA, Bhatt DL, Fonarow GC, Cannon CP, Cox M, Laskey W, Peacock WF, Hernandez AF, Peterson ED, Schwamm L, Saxon LA. Guideline adherence after ST-segment elevation versus non-ST segment elevation myocardial infarction. Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):654-61. doi: 10.1161/CIRCOUTCOMES.111.963959. Epub 2012 Sep 4.
  • DeBeradinis B, Januzzi JL Jr. Use of biomarkers to guide outpatient therapy of heart failure. Curr Opin Cardiol. 2012 Nov;27(6):661-8. doi: 10.1097/HCO.0b013e3283587c4d.
  • Lyman GH, Burstein HJ, Buzdar AU, D’Agostino R, Ellis PA. Making genuine progress against metastatic breast cancer. J Clin Oncol. 2012 Oct 1;30(28):3448-51. doi: 10.1200/JCO.2012.43.6931. Epub 2012 Aug 27.
  • Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Katus HA, Lindahl B, Morrow DA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasché P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S. Third universal definition of myocardial infarction. Circulation. 2012 Oct 16;126(16):2020-35. doi: 10.1161/CIR.0b013e31826e1058. Epub 2012 Aug 24.
  • Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Writing Group on the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Thygesen K, Alpert JS, White HD, Jaffe AS, Katus HA, Apple FS, Lindahl B, Morrow DA, Chaitman BA, Clemmensen PM, Johanson P, Hod H, Underwood R, Bax JJ, Bonow RO, Pinto F, Gibbons RJ, Fox KA, Atar D, Newby LK, Galvani M, Hamm CW, Uretsky BF, Steg PG, Wijns W, Bassand JP, Menasché P, Ravkilde J, Ohman EM, Antman EM, Wallentin LC, Armstrong PW, Simoons ML, Januzzi JL, Nieminen MS, Gheorghiade M, Filippatos G, Luepker RV, Fortmann SP, Rosamond WD, Levy D, Wood D, Smith SC, Hu D, Lopez-Sendon JL, Robertson RM, Weaver D, Tendera M, Bove AA, Parkhomenko AN, Vasilieva EJ, Mendis S; ESC Committee for Practice Guidelines (CPG). Third universal definition of myocardial infarction. Eur Heart J. 2012 Oct;33(20):2551-67. doi: 10.1093/eurheartj/ehs184. Epub 2012 Aug 24.
  • De Luca G, Gibson CM, Huber K, Dudek D, Cutlip D, Zeymer U, Gyöngyösi M, Bellandi F, Noc M, Arntz HR, Maioli M, Secco GG, Zorman S, Gabriel HM, Emre A, Rakowski T, Van’t Hof AW; EGYPT cooperation. Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation. EuroIntervention. 2012 Aug;8(4):470-6. doi: 10.4244/EIJV8I4A74.
  • Wang TJ, Wollert KC, Larson MG, Coglianese E, McCabe EL, Cheng S, Ho JE, Fradley MG, Ghorbani A, Xanthakis V, Kempf T, Benjamin EJ, Levy D, Vasan RS, Januzzi JL. Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study. Circulation. 2012 Sep 25;126(13):1596-604. doi: 10.1161/CIRCULATIONAHA.112.129437. Epub 2012 Aug 20.
  • Jukema JW, Cannon CP, de Craen AJ, Westendorp RG, Trompet S. The controversies of statin therapy: weighing the evidence. J Am Coll Cardiol. 2012 Sep 4;60(10):875-81. doi: 10.1016/j.jacc.2012.07.007. Epub 2012 Aug 15.
  • Cannon CP, Kohli P. Danger ahead: watch out for indirect comparisons!. J Am Coll Cardiol. 2012 Aug 21;60(8):747-8. doi: 10.1016/j.jacc.2012.05.012.
  • Elmariah S, Delaney JA, Bluemke DA, Budoff MJ, O’Brien KD, Fuster V, Kronmal RA, Halperin JL. Associations of LV hypertrophy with prevalent and incident valve calcification: Multi-Ethnic Study of Atherosclerosis. JACC Cardiovasc Imaging. 2012 Aug;5(8):781-8. doi: 10.1016/j.jcmg.2011.12.025.
  • Januzzi JL Jr, Maisel AS, Silver M, Xue Y, DeFilippi C. Natriuretic peptide testing for predicting adverse events following heart failure hospitalization. Congest Heart Fail. 2012 Sep-Oct;18 Suppl 1:S9-S13. doi: 10.1111/j.1751-7133.2012.00306.x.
  • Pang PS, Xue Y, Defilippi C, Silver M, Januzzi J, Maisel A. The role of natriuretic peptides: from the emergency department throughout hospitalization. Congest Heart Fail. 2012 Sep-Oct;18 Suppl 1:S5-8. doi: 10.1111/j.1751-7133.2012.00307.x.
  • Maisel A, Januzzi J, Xue Y, Silver MA. Post-acute care: the role of natriuretic peptides. Congest Heart Fail. 2012 Sep-Oct;18 Suppl 1:S14-6. doi: 10.1111/j.1751-7133.2012.00304.x.
  • Raheem S, Popma JJ. Clinical studies assessing transcatheter aortic valve replacement. Methodist Debakey Cardiovasc J. 2012 Apr-Jun;8(2):13-8. doi: 10.14797/mdcj-8-2-13.
  • Bangalore S, Kumar S, Fusaro M, Amoroso N, Kirtane AJ, Byrne RA, Williams DO, Slater J, Cutlip DE, Feit F. Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials. BMJ. 2012 Aug 10;345:e5170. doi: 10.1136/bmj.e5170.
  • Pencina MJ, D’Agostino RB, Demler OV, Janssens AC, Greenland P. Pencina et al. respond to “The incremental value of new markers” and “Clinically relevant measures? A note of caution”. Am J Epidemiol. 2012 Sep 15;176(6):492-4. doi: 10.1093/aje/kws206. Epub 2012 Aug 8.
  • Pencina MJ, D’Agostino RB, Pencina KM, Janssens AC, Greenland P. Interpreting incremental value of markers added to risk prediction models. Am J Epidemiol. 2012 Sep 15;176(6):473-81. doi: 10.1093/aje/kws207. Epub 2012 Aug 8.
  • Thurman RJ, Jauch EC, Panagos PD, Reynolds MR, Mocco J. Four evolving strategies in the emergent treatment of acute ischemic stroke. Emerg Med Pract. 2012 Jul;14(7):1-26; quiz 26-7.
  • Gaggin HK, Mohammed AA, Bhardwaj A, Rehman SU, Gregory SA, Weiner RB, Baggish AL, Moore SA, Semigran MJ, Januzzi JL Jr. Heart failure outcomes and benefits of NT-proBNP-guided management in the elderly: results from the prospective, randomized ProBNP outpatient tailored chronic heart failure therapy (PROTECT) study. J Card Fail. 2012 Aug;18(8):626-34. doi: 10.1016/j.cardfail.2012.05.005. Epub 2012 Jun 19.
  • Kirtane AJ, Pinto DS, Moses JW. Comparative effectiveness of revascularization strategies. N Engl J Med. 2012 Aug 2;367(5):476; author reply 477. doi: 10.1056/NEJMc1206011.
  • Cowan AJ, Seldin DC, Skinner M, Quillen K, Doros G, Tan J, O’Hara C, Finn KT, Sanchorawala V. Amyloid deposits in the bone marrow of patients with immunoglobulin light chain amyloidosis do not impact stem cell mobilization or engraftment. Biol Blood Marrow Transplant. 2012 Dec;18(12):1935-8. doi: 10.1016/j.bbmt.2012.07.016. Epub 2012 Jul 27.
  • Wimmer NJ, Yeh RW. Another view of personalized medicine: optimizing stent selection on the basis of predicted benefit in percutaneous coronary intervention. Trends Cardiovasc Med. 2012 Jan;22(1):23-8. doi: 10.1016/j.tcm.2012.06.006. Epub 2012 Jul 28.
  • Canto JG, Kiefe CI, Rogers WJ, Peterson ED, Frederick PD, French WJ, Gibson CM, Pollack CV Jr, Ornato JP, Zalenski RJ, Penney J, Tiefenbrunn AJ, Greenland P; NRMI Investigators. Atherosclerotic risk factors and their association with hospital mortality among patients with first myocardial infarction (from the National Registry of Myocardial Infarction). Am J Cardiol. 2012 Nov 1;110(9):1256-61. doi: 10.1016/j.amjcard.2012.06.025. Epub 2012 Jul 27.
  • Kimokoti RW, Gona P, Zhu L, Newby PK, Millen BE, Brown LS, D’Agostino RB, Fung TT. Dietary patterns of women are associated with incident abdominal obesity but not metabolic syndrome. J Nutr. 2012 Sep;142(9):1720-7. doi: 10.3945/jn.112.162479. Epub 2012 Jul 25.
  • Manzano-Fernández S, Januzzi JL, Pastor-Pérez FJ, Bonaque-González JC, Boronat-Garcia M, Pascual-Figal DA, Montalban-Larrea S, Navarro-Peñalver M, Andreu-Cayuelas JM, Valdés M. Serial monitoring of soluble interleukin family member ST2 in patients with acutely decompensated heart failure. Cardiology. 2012;122(3):158-66. doi: 10.1159/000338800. Epub 2012 Jul 24.
  • Zilinski JL, Shah RV, Gaggin HK, Gantzer ML, Wang TJ, Januzzi JL. Measurement of multiple biomarkers in advanced stage heart failure patients treated with pulmonary artery catheter guided therapy. Crit Care. 2012 Jul 25;16(4):R135. doi: 10.1186/cc11440.
  • Chakrabarti AK, Singh P, Gopalakrishnan L, Kumar V, Elizabeth Doherty M, Abueg C, Wang W, Gibson CM. Admission hyperglycemia and acute myocardial infarction: outcomes and potential therapies for diabetics and nondiabetics. Cardiol Res Pract. 2012;2012:704314. doi: 10.1155/2012/704314. Epub 2012 Jul 9.
  • Kramer DB, Baker M, Ransford B, Molina-Markham A, Stewart Q, Fu K, Reynolds MR. Security and privacy qualities of medical devices: an analysis of FDA postmarket surveillance. PLoS One. 2012;7(7):e40200. doi: 10.1371/journal.pone.0040200. Epub 2012 Jul 19.
  • Vranckx P, McFadden E, Mehran R, Cutlip DE. Clinical event committees in coronary stent trials: insights and recommendations based on experience in an unselected study population. EuroIntervention. 2012 Jul 20;8(3):368-74. doi: 10.4244/EIJV8I3A56.
  • Tan TW, Kalish JA, Hamburg NM, Rybin D, Doros G, Eberhardt RT, Farber A. Shorter duration of femoral-popliteal bypass is associated with decreased surgical site infection and shorter hospital length of stay. J Am Coll Surg. 2012 Oct;215(4):512-8. doi: 10.1016/j.jamcollsurg.2012.06.007. Epub 2012 Jul 21.
  • Manzano-Fernández S, López-Cuenca A, Januzzi JL, Parra-Pallares S, Mateo-Martínez A, Sánchez-Martínez M, Pérez-Berbel P, Orenes-Piñero E, Romero-Aniorte AI, Avilés-Plaza F, Valdés-Chavarri M, Marín F. Usefulness of β-trace protein and cystatin C for the prediction of mortality in non ST segment elevation acute coronary syndromes. Am J Cardiol. 2012 Nov 1;110(9):1240-8. doi: 10.1016/j.amjcard.2012.06.027. Epub 2012 Jul 19.
  • Reynolds MR, Magnuson EA, Wang K, Thourani VH, Williams M, Zajarias A, Rihal CS, Brown DL, Smith CR, Leon MB, Cohen DJ; PARTNER Trial Investigators. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiol. 2012 Aug 7;60(6):548-58. doi: 10.1016/j.jacc.2012.03.075. Epub 2012 Jul 18.
  • D’Agostino RB Sr, Pencina MJ. Invited commentary: Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance. Am J Epidemiol. 2012 Aug 1;176(3):187-9. doi: 10.1093/aje/kws203. Epub 2012 Jul 19.
  • Rowin EJ, Maron BJ, Appelbaum E, Link MS, Gibson CM, Lesser JR, Haas TS, Udelson JE, Manning WJ, Maron MS. Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy. Am J Cardiol. 2012 Oct 1;110(7):1027-32. doi: 10.1016/j.amjcard.2012.05.035. Epub 2012 Jul 16.
  • Rivara MB, Bajwa EK, Januzzi JL, Gong MN, Thompson BT, Christiani DC. Prognostic significance of elevated cardiac troponin-T levels in acute respiratory distress syndrome patients. PLoS One. 2012;7(7):e40515. doi: 10.1371/journal.pone.0040515. Epub 2012 Jul 12.
  • D’Agostino R Sr, DeMets D, Friedewald W, Goodman S, Witte J, Geller NL. The future of clinical trials: A panel discussion. Stat Med. 2012 Nov 10;31(25):3068-72. doi: 10.1002/sim.5484. Epub 2012 Jul 16.
  • Kunz LM, Yeh RW, Normand SL. Comparative effectiveness research: does one size fit all?. Stat Med. 2012 Nov 10;31(25):3062-5; discussion 3066-7. doi: 10.1002/sim.5482. Epub 2012 Jul 16.
  • Emerging Risk Factors Collaboration, Di Angelantonio E, Gao P, Pennells L, Kaptoge S, Caslake M, Thompson A, Butterworth AS, Sarwar N, Wormser D, Saleheen D, Ballantyne CM, Psaty BM, Sundström J, Ridker PM, Nagel D, Gillum RF, Ford I, Ducimetiere P, Kiechl S, Koenig W, Dullaart RP, Assmann G, D’Agostino RB Sr, Dagenais GR, Cooper JA, Kromhout D, Onat A, Tipping RW, Gómez-de-la-Cámara A, Rosengren A, Sutherland SE, Gallacher J, Fowkes FG, Casiglia E, Hofman A, Salomaa V, Barrett-Connor E, Clarke R, Brunner E, Jukema JW, Simons LA, Sandhu M, Wareham NJ, Khaw KT, Kauhanen J, Salonen JT, Howard WJ, Nordestgaard BG, Wood AM, Thompson SG, Boekholdt SM, Sattar N, Packard C, Gudnason V, Danesh J. Lipid-related markers and cardiovascular disease prediction. JAMA. 2012 Jun 20;307(23):2499-506. doi: 10.1001/jama.2012.6571.
  • deFilippi C, Seliger SL, Kelley W, Duh SH, Hise M, Christenson RH, Wolf M, Gaggin H, Januzzi J. Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome. Clin Chem. 2012 Sep;58(9):1342-51. doi: 10.1373/clinchem.2012.185322. Epub 2012 Jul 12.
  • Maioli M, Zeymer U, van ‘t Hof AW, Gibson CM, Dudek D, Bellandi F, Noc M, Secco GG, Zorman S, Gabriel HM, Emre A, Cutlip D, Rakowski T, Gyongyosi M, Huber K, De Luca G; EGYPT Cooperation. Impact of preprocedural TIMI flow on myocardial perfusion, distal embolization and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb/IIIa inhibitors. J Invasive Cardiol. 2012 Jul;24(7):324-7.
  • Amin AP, Spertus JA, Cohen DJ, Chhatriwalla A, Kennedy KF, Vilain K, Salisbury AC, Venkitachalam L, Lai SM, Mauri L, Normand SL, Rumsfeld JS, Messenger JC, Yeh RW. Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice. Arch Intern Med. 2012 Aug 13;172(15):1145-52. doi: 10.1001/archinternmed.2012.3093.
  • O’Donoghue ML, Vaidya A, Afsal R, Alfredsson J, Boden WE, Braunwald E, Cannon CP, Clayton TC, de Winter RJ, Fox KA, Lagerqvist B, McCullough PA, Murphy SA, Spacek R, Swahn E, Windhausen F, Sabatine MS. An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a collaborative meta-analysis of randomized trials. J Am Coll Cardiol. 2012 Jul 10;60(2):106-11. doi: 10.1016/j.jacc.2012.02.059.
  • Rothman RD, Baggish AL, O’Callaghan C, Lowry PA, Bhatt AB, MacRae CA, Yannekis G, Sanborn DM, Mela T, Yeh RW, Palacios I, Vlahakes GJ, Fifer MA. Management strategy in 249 consecutive patients with obstructive hypertrophic cardiomyopathy referred to a dedicated program. Am J Cardiol. 2012 Oct 15;110(8):1169-74. doi: 10.1016/j.amjcard.2012.05.056. Epub 2012 Jul 4.
  • Oren-Grinberg A, Gulati G, Fuchs L, Pinto DS. Hand-held echocardiography in the management of cardiac arrest. Anesth Analg. 2012 Nov;115(5):1038-41. doi: 10.1213/ANE.0b013e318261f7a0. Epub 2012 Jul 4.
  • Steen DL, Cannon CP. Atherosclerosis. Effects of evacetrapib administered as monotherapy or in combination with statins. Rev Cardiovasc Med. 2012;13(1):e48-51.
  • Huang PH, Kim CX, Lerman A, Cannon CP, Dai D, Laskey W, Peacock WF, Hernandez AF, Peterson ED, Smith EE, Fonarow GC, Schwamm LH, Bhatt DL. Trends in smoking cessation counseling: experience from American Heart Association-get with the guidelines. Clin Cardiol. 2012;35(7):396-403. doi: 10.1002/clc.22023.
  • Bangalore S, Fonarow GC, Peterson ED, Hellkamp AS, Hernandez AF, Laskey W, Peacock WF, Cannon CP, Schwamm LH, Bhatt DL; Get with the Guidelines Steering Committee and Investigators. Age and gender differences in quality of care and outcomes for patients with ST-segment elevation myocardial infarction. Am J Med. 2012 Oct;125(10):1000-9. doi: 10.1016/j.amjmed.2011.11.016. Epub 2012 Jun 27.
  • Rastogi SK, Gibson CM, Branen JR, Aston DE, Branen AL, Hrdlicka PJ. DNA detection on lateral flow test strips: enhanced signal sensitivity using LNA-conjugated gold nanoparticles. Chem Commun (Camb). 2012 Aug 11;48(62):7714-6. doi: 10.1039/c2cc33430e. Epub 2012 Jun 29.
  • Januzzi JL Jr, Filippatos G, Nieminen M, Gheorghiade M. Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section. Eur Heart J. 2012 Sep;33(18):2265-71. doi: 10.1093/eurheartj/ehs191. Epub 2012 Jun 28.
  • Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Tan TC, Cohen V, Banchs J, Carver JR, Wiegers SE, Martin RP, Picard MH, Gerszten RE, Halpern EF, Passeri J, Kuter I, Scherrer-Crosbie M. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging. 2012 Sep 1;5(5):596-603. doi: 10.1161/CIRCIMAGING.112.973321. Epub 2012 Jun 28.
  • Medina HM, Cannon CP, Fonarow GC, Grau-Sepulveda MV, Hernandez AF, Frank Peacock W, Laskey W, Peterson ED, Schwamm L, Bhatt DL; GWTG Steering Committee and Investigators. Reperfusion strategies and quality of care in 5339 patients age 80 years or older presenting with ST-elevation myocardial infarction: analysis from get with the guidelines-coronary artery disease. Clin Cardiol. 2012 Oct;35(10):632-40. doi: 10.1002/clc.22036. Epub 2012 Jun 28.
  • Vasaiwala S, Cannon CP, Fonarow GC, Peacock WF, Laskey W, Schwamm LH, Liang L, Hernandez AF, Peterson ED, Rosas SE, Bhatt DL; Get With The Guidelines Steering Committee and Investigators. Quality of care and outcomes among patients with acute myocardial infarction by level of kidney function at admission: report from the get with the guidelines coronary artery disease program. Clin Cardiol. 2012 Sep;35(9):541-7. doi: 10.1002/clc.22021. Epub 2012 Jun 28.
  • Grinstein J, Cannon CP. Aspirin resistance: current status and role of tailored therapy. Clin Cardiol. 2012 Nov;35(11):673-81. doi: 10.1002/clc.22031. Epub 2012 Jun 27.
  • Mebazaa A, Vanpoucke G, Thomas G, Verleysen K, Cohen-Solal A, Vanderheyden M, Bartunek J, Mueller C, Launay JM, Van Landuyt N, D’Hondt F, Verschuere E, Vanhaute C, Tuytten R, Vanneste L, De Cremer K, Wuyts J, Davies H, Moerman P, Logeart D, Collet C, Lortat-Jacob B, Tavares M, Laroy W, Januzzi JL, Samuel JL, Kas K. Unbiased plasma proteomics for novel diagnostic biomarkers in cardiovascular disease: identification of quiescin Q6 as a candidate biomarker of acutely decompensated heart failure. Eur Heart J. 2012 Sep;33(18):2317-24. doi: 10.1093/eurheartj/ehs162. Epub 2012 Jun 24.
  • Wilson PW, D’Agostino R Sr, Bhatt DL, Eagle K, Pencina MJ, Smith SC, Alberts MJ, Dallongeville J, Goto S, Hirsch AT, Liau CS, Ohman EM, Röther J, Reid C, Mas JL, Steg PG; REACH Registry. An international model to predict recurrent cardiovascular disease. Am J Med. 2012 Jul;125(7):695-703.e1. doi: 10.1016/j.amjmed.2012.01.014.
  • Yonetsu T, Kim JS, Kato K, Kim SJ, Xing L, Yeh RW, Sakhuja R, McNulty I, Lee H, Zhang S, Uemura S, Yu B, Kakuta T, Jang IK. Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography. Am J Cardiol. 2012 Oct 1;110(7):933-9. doi: 10.1016/j.amjcard.2012.05.027. Epub 2012 Jun 20.
  • Polak JF, Meisner A, Pencina MJ, Wolf PA, D’Agostino RB. Variations in common carotid artery intima-media thickness during the cardiac cycle: implications for cardiovascular risk assessment. J Am Soc Echocardiogr. 2012 Sep;25(9):1023-8. doi: 10.1016/j.echo.2012.05.007. Epub 2012 Jun 20.
  • Hao SC, Hunter TD, Gunnarsson C, March JL, White SA, Ladapo JA, Reynolds MR. Acute safety outcomes in younger and older patients with atrial fibrillation treated with catheter ablation. J Interv Card Electrophysiol. 2012 Nov;35(2):173-82. doi: 10.1007/s10840-012-9690-5. Epub 2012 Jun 20.
  • Duval S, Massaro JM, Jaff MR, Boden WE, Alberts MJ, Califf RM, Eagle KA, D’Agostino RB Sr, Pedley A, Fonarow GC, Murabito JM, Steg PG, Bhatt DL, Hirsch AT; REACH Registry Investigators. An evidence-based score to detect prevalent peripheral artery disease (PAD). Vasc Med. 2012 Oct;17(5):342-51. doi: 10.1177/1358863X12445102. Epub 2012 Jun 17.
  • Pascual-Figal DA, Casas T, Ordonez-Llanos J, Manzano-Fernández S, Bonaque JC, Boronat M, Muñoz-Esparza C, Valdés M, Januzzi JL. Highly sensitive troponin T for risk stratification of acutely destabilized heart failure. Am Heart J. 2012 Jun;163(6):1002-10. doi: 10.1016/j.ahj.2012.03.015.
  • Truong QA, Bayley J, Hoffmann U, Bamberg F, Schlett CL, Nagurney JT, Koenig W, Januzzi JL. Multi-marker strategy of natriuretic peptide with either conventional or high-sensitivity troponin-T for acute coronary syndrome diagnosis in emergency department patients with chest pain: from the “Rule Out Myocardial Infarction using Computer Assisted Tomography” (ROMICAT) trial. Am Heart J. 2012 Jun;163(6):972-979.e1. doi: 10.1016/j.ahj.2012.03.010. Epub 2012 May 21.
  • Cannon CP, Cannon PJ. Physiology. COX-2 inhibitors and cardiovascular risk. Science. 2012 Jun 15;336(6087):1386-7. doi: 10.1126/science.1224398.
  • Attia A, Rapp SR, Case LD, D’Agostino R, Lesser G, Naughton M, McMullen K, Rosdhal R, Shaw EG. Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood. J Neurooncol. 2012 Sep;109(2):357-63. doi: 10.1007/s11060-012-0901-9. Epub 2012 Jun 15.
  • Kato K, Yonetsu T, Kim SJ, Xing L, Lee H, McNulty I, Yeh RW, Sakhuja R, Zhang S, Uemura S, Yu B, Mizuno K, Jang IK. Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging. 2012 Jul;5(4):433-40. doi: 10.1161/CIRCIMAGING.112.973701. Epub 2012 Jun 7.
  • Armstrong EJ, Xing L, Zhang J, Zheng Y, Shunk KA, Yeh RW, Farzaneh-Far R, Yu B, Jang IK. Association between leukocyte telomere length and drug-eluting stent strut coverage by optical coherence tomography. J Am Coll Cardiol. 2012 Jun 12;59(24):2218-9. doi: 10.1016/j.jacc.2012.03.028.
  • Joshi PH, Chaudhari S, Blaha MJ, Jones SR, Martin SS, Post WS, Cannon CP, Fonarow GC, Wong ND, Amsterdam E, Hirshfeld JW, Blumenthal RS. A point-by-point response to recent arguments against the use of statins in primary prevention: this statement is endorsed by the American Society for Preventive Cardiology. Clin Cardiol. 2012;35(7):404-9. doi: 10.1002/clc.22016. Epub 2012 Jun 6.
  • Gibson CM, Kao RH, Blevins KK, Travers PD. Integrative taxonomy for continental-scale terrestrial insect observations. PLoS One. 2012;7(5):e37528. doi: 10.1371/journal.pone.0037528. Epub 2012 May 29.
  • Burke DA, Warraich HJ, Pinto DS. Which antithrombin for whom? Identifying the patient population that benefits most from novel antithrombin agents. Curr Cardiol Rep. 2012 Aug;14(4):493-501. doi: 10.1007/s11886-012-0286-6.
  • Amin AP, Reynolds MR, Lei Y, Magnuson EA, Vilain K, Durtschi AJ, Simonton CA, Stone GW, Cohen DJ. Cost-effectiveness of everolimus- versus paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization (from the SPIRIT-IV Trial). Am J Cardiol. 2012 Sep 15;110(6):765-70. doi: 10.1016/j.amjcard.2012.05.006. Epub 2012 May 30.
  • Welsh RC, Rao SV, Zeymer U, Thompson VP, Huber K, Kochman J, McClure MW, Gretler DD, Bhatt DL, Gibson CM, Angiolillo DJ, Gurbel PA, Berdan LG, Paynter G, Leonardi S, Madan M, French WJ, Harrington RA; INNOVATE-PCI Investigators. A randomized, double-blind, active-controlled phase 2 trial to evaluate a novel selective and reversible intravenous and oral P2Y12 inhibitor elinogrel versus clopidogrel in patients undergoing nonurgent percutaneous coronary intervention: the INNOVATE-PCI trial. Circ Cardiovasc Interv. 2012 Jun;5(3):336-46. doi: 10.1161/CIRCINTERVENTIONS.111.964197. Epub 2012 May 29.
  • Piccini JP, White JA, Mehta RH, Lokhnygina Y, Al-Khatib SM, Tricoci P, Pollack CV Jr, Montalescot G, Van de Werf F, Gibson CM, Giugliano RP, Califf RM, Harrington RA, Newby LK. Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes. Circulation. 2012 Jul 3;126(1):41-9. doi: 10.1161/CIRCULATIONAHA.111.071860. Epub 2012 May 29.
  • Shah RV, Truong QA, Gaggin HK, Pfannkuche J, Hartmann O, Januzzi JL Jr. Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea. Eur Heart J. 2012 Sep;33(17):2197-205. doi: 10.1093/eurheartj/ehs136. Epub 2012 May 29.
  • Lackland DT, Elkind MS, D’Agostino R Sr, Dhamoon MS, Goff DC Jr, Higashida RT, McClure LA, Mitchell PH, Sacco RL, Sila CA, Smith SC Jr, Tanne D, Tirschwell DL, Touzé E, Wechsler LR; American Heart Association Stroke Council; Council on Epidemiology and Prevention; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease; Council on Quality of Care and Outcomes Research. Inclusion of stroke in cardiovascular risk prediction instruments: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2012 Jul;43(7):1998-2027. doi: 10.1161/STR.0b013e31825bcdac. Epub 2012 May 24.
  • Mueller M, Celik S, Biener M, Vafaie M, Schwoebel K, Wollert KC, Januzzi JL, Katus HA, Giannitsis E. Diagnostic and prognostic performance of a novel high-sensitivity cardiac troponin T assay compared to a contemporary sensitive cardiac troponin I assay in patients with acute coronary syndrome. Clin Res Cardiol. 2012 Oct;101(10):837-45. doi: 10.1007/s00392-012-0469-6. Epub 2012 May 25.
  • Bander J, Elmariah S, Aledort LM, Dlott J, Stelzer P, Halperin JL, Kini AS, Sharma SK. Changes in von Willebrand factor-cleaving protease (ADAMTS-13) in patients with aortic stenosis undergoing valve replacement or balloon valvuloplasty. Thromb Haemost. 2012 Jul;108(1):86-93. doi: 10.1160/TH11-12-0803. Epub 2012 May 25.
  • Elmariah S, Arzamendi D, Llanos A, Margey RJ, Inglessis I, Passeri JJ, Mehrotra P, Baker JN, Rosenfield K, Agnihotri AK, Vlahakes GJ, Palacios IF. First experience with transcatheter valve-in-valve implantation for a stenotic mitral prosthesis within the United States. JACC Cardiovasc Interv. 2012 May;5(5):e13-e14. doi: 10.1016/j.jcin.2012.01.020.
  • Bagur R, Rodés-Cabau J, Gurvitch R, Dumont É, Velianou JL, Manazzoni J, Toggweiler S, Cheung A, Ye J, Natarajan MK, Bainey KR, DeLarochellière R, Doyle D, Pibarot P, Voisine P, Côté M, Philippon F, Webb JG. Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings. JACC Cardiovasc Interv. 2012 May;5(5):540-551. doi: 10.1016/j.jcin.2012.03.004.
  • Steinberg BA, Zhao X, Heidenreich PA, Peterson ED, Bhatt DL, Cannon CP, Hernandez AF, Fonarow GC; Get With the Guidelines Scientific Advisory Committee and Investigators. Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes. Circulation. 2012 Jul 3;126(1):65-75. doi: 10.1161/CIRCULATIONAHA.111.080770. Epub 2012 May 21.
  • Akpek M, Kaya MG, Lam YY, Sahin O, Elcik D, Celik T, Ergin A, Gibson CM. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol. 2012 Sep 1;110(5):621-7. doi: 10.1016/j.amjcard.2012.04.041. Epub 2012 May 18.
  • van Kimmenade RR, Januzzi JL. Red cell distribution width measurement: what role does it have in heart failure?. Rev Esp Cardiol (Engl Ed). 2012 Jul;65(7):593-4. doi: 10.1016/j.recesp.2012.02.018. Epub 2012 May 17.
  • Leonardi S, Mahaffey KW, White HD, Gibson CM, Stone GW, Steg GW, Hamm CW, Price MJ, Todd M, Dietrich M, Gallup D, Liu T, Skerjanec S, Harrington RA, Bhatt DL. Rationale and design of the Cangrelor versus standard therapy to acHieve optimal Management of Platelet InhibitiON PHOENIX trial. Am Heart J. 2012 May;163(5):768-776.e2. doi: 10.1016/j.ahj.2012.02.018.
  • Gopalakrishnan L, Kumar V, Kohli P, Singh P, Rastogi U, Gibson CM. Pharmacokinetic evaluation of rivaroxaban for the treatment of acute coronary syndromes. Expert Opin Drug Metab Toxicol. 2012 Jul;8(7):889-900. doi: 10.1517/17425255.2012.688026. Epub 2012 May 11.
  • D’Agostino RB Sr. Cardiovascular risk estimation in 2012: lessons learned and applicability to the HIV population. J Infect Dis. 2012 Jun;205 Suppl 3(Suppl 3):S362-7. doi: 10.1093/infdis/jis196.
  • Bashore TM, Balter S, Barac A, Byrne JG, Cavendish JJ, Chambers CE, Hermiller JB Jr, Kinlay S, Landzberg JS, Laskey WK, McKay CR, Miller JM, Moliterno DJ, Moore JW, Oliver-McNeil SM, Popma JJ, Tommaso CL; ACCF Task Force Members. 2012 American College of Cardiology Foundation/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update: A report of the American College of Cardiology Foundation Task Force on Expert Consensus documents developed in collaboration with the Society of Thoracic Surgeons and Society for Vascular Medicine. J Am Coll Cardiol. 2012 Jun 12;59(24):2221-305. doi: 10.1016/j.jacc.2012.02.010. Epub 2012 May 8.
  • Shahian DM, Meyer GS, Yeh RW, Fifer MA, Torchiana DF. Percutaneous coronary interventions without on-site cardiac surgical backup. N Engl J Med. 2012 May 10;366(19):1814-23. doi: 10.1056/NEJMra1109616.
  • Bashore TM, Balter S, Barac A, Byrne JG, Cavendish JJ, Chambers CE, Hermiller JB Jr, Kinlay S, Landzberg JS, Laskey WK, McKay CR, Miller JM, Moliterno DJ, Moore JW, Oliver-McNeil SM, Popma JJ, Gardner; American College of Cardiology Foundation; Society for Cardiovascular Angiography and Interventions; Society fof Thoracic Surgeons; Society for Vascular Medicine. 2012 American College of Cardiology Foundation/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update: American College of Cardiology Foundation Task Force on expert consensus documents Society of Thoracic Surgeons Society for Vascular Medicine. Catheter Cardiovasc Interv. 2012 Sep 1;80(3):E37-49. doi: 10.1002/ccd.24466. Epub 2012 May 8.
  • Kastellorizios M, Michanetzis GP, Pistillo BR, Mourtas S, Klepetsanis P, Favia P, Sardella E, d’Agostino R, Missirlis YF, Antimisiaris SG. Haemocompatibility improvement of metallic surfaces by covalent immobilization of heparin-liposomes. Int J Pharm. 2012 Aug 1;432(1-2):91-8. doi: 10.1016/j.ijpharm.2012.04.057. Epub 2012 Apr 28.
  • Reynolds MR, Weiler AM, Piaskowski SM, Piatak M Jr, Robertson HT, Allison DB, Bett AJ, Casimiro DR, Shiver JW, Wilson NA, Lifson JD, Koff WC, Watkins DI. A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge. Vaccine. 2012 Jun 22;30(30):4465-75. doi: 10.1016/j.vaccine.2012.04.082. Epub 2012 May 6.
  • Maron MS, Rowin EJ, Lin D, Appelbaum E, Chan RH, Gibson CM, Lesser JR, Lindberg J, Haas TS, Udelson JE, Manning WJ, Maron BJ. Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. 2012 Jul;5(4):441-7. doi: 10.1161/CIRCIMAGING.112.972760. Epub 2012 May 4.
  • Pencina MJ, D’Agostino RB Sr. Thoroughly modern risk prediction?. Sci Transl Med. 2012 Apr 25;4(131):131fs10. doi: 10.1126/scitranslmed.3004127.
  • Matlock DD, Peterson PN, Wang Y, Curtis JP, Reynolds MR, Varosy PD, Masoudi FA. Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry. Arch Intern Med. 2012 Apr 23;172(8):634-41; discussion 641. doi: 10.1001/archinternmed.2012.394.
  • Charytan DM, Stern NM, Mauri L. CKD and coronary collateral supply in individuals undergoing coronary angiography after myocardial infarction. Clin J Am Soc Nephrol. 2012 Jul;7(7):1079-86. doi: 10.2215/CJN.11171111. Epub 2012 Apr 19.
  • Vranckx P, Cutlip DE, McFadden EP, Kern MJ, Mehran R, Muller O. Coronary pressure-derived fractional flow reserve measurements: recommendations for standardization, recording, and reporting as a core laboratory technique. Proposals for integration in clinical trials. Circ Cardiovasc Interv. 2012 Apr;5(2):312-7. doi: 10.1161/CIRCINTERVENTIONS.112.968511.
  • Kohli P, Cannon CP. A new approach to managing the ‘statin-intolerant’ patient?. Eur Heart J. 2012 May;33(9):1040-3. doi: 10.1093/eurheartj/ehs062. Epub 2012 Apr 16.
  • Ho JE, Gona P, Pencina MJ, Tu JV, Austin PC, Vasan RS, Kannel WB, D’Agostino RB, Lee DS, Levy D. Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community. Eur Heart J. 2012 Jul;33(14):1734-41. doi: 10.1093/eurheartj/ehs070. Epub 2012 Apr 16.
  • Martin SS, Metkus TS, Horne A, Blaha MJ, Hasan R, Campbell CY, Yousuf O, Joshi P, Kaul S, Miller M, Michos ED, Jones SR, Gluckman TJ, Cannon CP, Sperling LS, Blumenthal RS. Waiting for the National Cholesterol Education Program Adult Treatment Panel IV Guidelines, and in the meantime, some challenges and recommendations. Am J Cardiol. 2012 Jul 15;110(2):307-13. doi: 10.1016/j.amjcard.2012.03.023. Epub 2012 Apr 10.
  • Venkitachalam L, Wang K, Porath A, Corbalan R, Hirsch AT, Cohen DJ, Smith SC Jr, Ohman EM, Steg PG, Bhatt DL, Magnuson EA; REACH Registry Investigators. Global variation in the prevalence of elevated cholesterol in outpatients with established vascular disease or 3 cardiovascular risk factors according to national indices of economic development and health system performance. Circulation. 2012 Apr 17;125(15):1858-69. doi: 10.1161/CIRCULATIONAHA.111.064378. Epub 2012 Apr 9.
  • Stead W, O’Halloran TD, Bernier M, Zimetbaum PJ, Irish J. Using interprofessional education strategies to improve collaborative attitudes among infectious diseases and cardiology physician trainees. Med Teach. 2012;34(7):594-5. doi: 10.3109/0142159X.2012.675102. Epub 2012 Apr 10.
  • Jaacks LM, Oza-Frank R, D’Agostino R Jr, Dolan LM, Dabelea D, Lawrence JM, Pihoker C, O’Connor MR, Linder B, Imperatore G, Seid M, Narayan KM, Mayer-Davis EJ. Migration status in relation to clinical characteristics and barriers to care among youth with diabetes in the US. J Immigr Minor Health. 2012 Dec;14(6):949-58. doi: 10.1007/s10903-012-9617-3.
  • Gaggin HK, Januzzi JL Jr. What is the role of serial high-sensitivity troponin measurements in chronic heart failure?. Clin Chem. 2012 Jul;58(7):1079-81. doi: 10.1373/clinchem.2012.183244. Epub 2012 Apr 3.
  • Reynolds MR, Panagos PD, Zipfel GJ, Lee JM, Derdeyn CP. Elements of a stroke center. Tech Vasc Interv Radiol. 2012 Mar;15(1):5-9. doi: 10.1053/j.tvir.2011.12.010.
  • Selker HP, Beshansky JR, Sheehan PR, Massaro JM, Griffith JL, D’Agostino RB, Ruthazer R, Atkins JM, Sayah AJ, Levy MK, Richards ME, Aufderheide TP, Braude DA, Pirrallo RG, Doyle DD, Frascone RJ, Kosiak DJ, Leaming JM, Van Gelder CM, Walter GP, Wayne MA, Woolard RH, Opie LH, Rackley CE, Apstein CS, Udelson JE. Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial. JAMA. 2012 May 9;307(18):1925-33. doi: 10.1001/jama.2012.426. Epub 2012 Mar 27.
  • Weintraub WS, Grau-Sepulveda MV, Weiss JM, O’Brien SM, Peterson ED, Kolm P, Zhang Z, Klein LW, Shaw RE, McKay C, Ritzenthaler LL, Popma JJ, Messenger JC, Shahian DM, Grover FL, Mayer JE, Shewan CM, Garratt KN, Moussa ID, Dangas GD, Edwards FH. Comparative effectiveness of revascularization strategies. N Engl J Med. 2012 Apr 19;366(16):1467-76. doi: 10.1056/NEJMoa1110717. Epub 2012 Mar 27.
  • Hebel E, Middleton B, Shubina M, Turchin A. Bridging the chasm: effect of health information exchange on volume of laboratory testing. Arch Intern Med. 2012 Mar 26;172(6):517-9. doi: 10.1001/archinternmed.2011.2104.
  • Stone GW, Maehara A, Witzenbichler B, Godlewski J, Parise H, Dambrink JH, Ochala A, Carlton TW, Cristea E, Wolff SD, Brener SJ, Chowdhary S, El-Omar M, Neunteufl T, Metzger DC, Karwoski T, Dizon JM, Mehran R, Gibson CM; INFUSE-AMI Investigators. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. JAMA. 2012 May 2;307(17):1817-26. doi: 10.1001/jama.2012.421. Epub 2012 Mar 25.
  • Bui AH, Bonaca MP, Sabatine MS, Ray KK, Rifai N, Cannon CP, Morrow DA. Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial. J Thromb Thrombolysis. 2012 Aug;34(2):222-8. doi: 10.1007/s11239-012-0704-z.
  • Kereiakes DJ, Popma JJ, Cannon LA, Kandzari DE, Kimmelstiel CD, Meredith IT, Teirstein PS, Verheye S, Allocco DJ, Dawkins KD, Stone GW. Longitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trials. EuroIntervention. 2012 Jun 20;8(2):187-95. doi: 10.4244/EIJV8I2A32.
  • Burmeister D, AbouShwareb T, D’Agostino R Jr, Andersson KE, Christ GJ. Impact of partial urethral obstruction on bladder function: time-dependent changes and functional correlates of altered expression of Ca²⁺ signaling regulators. Am J Physiol Renal Physiol. 2012 Jun 15;302(12):F1517-28. doi: 10.1152/ajprenal.00016.2012. Epub 2012 Mar 21.
  • Yeh RW, Rosenfield K, Zelevinsky K, Mauri L, Sakhuja R, Shivapour DM, Lovett A, Weiner BH, Jacobs AK, Normand SL. Sources of hospital variation in short-term readmission rates after percutaneous coronary intervention. Circ Cardiovasc Interv. 2012 Apr;5(2):227-36. doi: 10.1161/CIRCINTERVENTIONS.111.967638. Epub 2012 Mar 20.
  • Pervaiz MH, Sood P, Sudhir K, Hermiller JB, Hou L, Hattori K, Su X, Cao S, Wang J, Applegate RJ, Kereiakes DJ, Yaqub M, Stone GW, Cutlip DE. Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and Paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitions. Circ Cardiovasc Interv. 2012 Apr;5(2):150-6. doi: 10.1161/CIRCINTERVENTIONS.111.965566. Epub 2012 Mar 20.
  • Caro MA, Sowden GL, Mastromauro CA, Mahnks S, Beach SR, Januzzi JL, Huffman JC. Risk factors for positive depression screens in hospitalized cardiac patients. J Cardiol. 2012 Jul;60(1):72-7. doi: 10.1016/j.jjcc.2012.01.016. Epub 2012 Mar 20.
  • Alli OO, Teirstein PS, Satler L, Sketch MH Jr, Popma JJ, Mauri L, Wang HP, Schleckser PA, Cohen SA, Holmes DR Jr; SISR Investigators. Five-year follow-up of the Sirolimus-Eluting Stents vs Vascular Brachytherapy for Bare Metal In-Stent Restenosis (SISR) trial. Am Heart J. 2012 Mar;163(3):438-45. doi: 10.1016/j.ahj.2011.11.019.
  • Selker HP, Beshansky JR, Griffith JL, D’Agostino RB, Massaro JM, Udelson JE, Rashba EJ, Ruthazer R, Sheehan PR, Desvigne-Nickens P, Rosenberg YD, Atkins JM, Sayah AJ, Aufderheide TP, Rackley CE, Opie LH, Lambrew CT, Cobb LA, Macleod BA, Ingwall JS, Zalenski RJ, Apstein CS. Study design for the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care (IMMEDIATE) Trial: A double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary syndromes in emergency medical services. Am Heart J. 2012 Mar;163(3):315-22. doi: 10.1016/j.ahj.2012.02.002.
  • Narasimhan S, McKay K, Bainey KR. Coronary artery disease in South Asians. Cardiol Rev. 2012 Nov-Dec;20(6):304-11. doi: 10.1097/CRD.0b013e3182532286.
  • Demler OV, Pencina MJ, D’Agostino RB Sr. Misuse of DeLong test to compare AUCs for nested models. Stat Med. 2012 Oct 15;31(23):2577-87. doi: 10.1002/sim.5328. Epub 2012 Mar 13.
  • Reynolds MR, Vega RA, Murphy RK, Miller-Thomas MM, Zipfel GJ. Perimesencephalic subarachnoid hemorrhage associated with a painless, pupillary-involving third cranial nerve palsy: case report and literature review. Clin Neurol Neurosurg. 2012 Oct;114(8):1168-71. doi: 10.1016/j.clineuro.2012.02.028. Epub 2012 Mar 10.
  • Rosas HD, Chen YI, Doros G, Salat DH, Chen NK, Kwong KK, Bush A, Fox J, Hersch SM. Alterations in brain transition metals in Huntington disease: an evolving and intricate story. Arch Neurol. 2012 Jul;69(7):887-93. doi: 10.1001/archneurol.2011.2945.
  • Kohli P, Cannon CP. Triglycerides: how much credit do they deserve?. Med Clin North Am. 2012 Jan;96(1):39-55. doi: 10.1016/j.mcna.2011.11.006.
  • Reynolds MR, Gunnarsson CL, Hunter TD, Ladapo JA, March JL, Zhang M, Hao SC. Health outcomes with catheter ablation or antiarrhythmic drug therapy in atrial fibrillation: results of a propensity-matched analysis. Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):171-81. doi: 10.1161/CIRCOUTCOMES.111.963108. Epub 2012 Feb 28.
  • Novack V, Pencina M, Cohen DJ, Kleiman NS, Yen CH, Saucedo JF, Berger PB, Cutlip DE. Troponin criteria for myocardial infarction after percutaneous coronary intervention. Arch Intern Med. 2012 Mar 26;172(6):502-8. doi: 10.1001/archinternmed.2011.2275. Epub 2012 Feb 27.
  • Januzzi JL Jr. The role of natriuretic peptide testing in guiding chronic heart failure management: review of available data and recommendations for use. Arch Cardiovasc Dis. 2012 Jan;105(1):40-50. doi: 10.1016/j.acvd.2011.10.007. Epub 2012 Jan 16.
  • Corbacioglu S, Cesaro S, Faraci M, Valteau-Couanet D, Gruhn B, Rovelli A, Boelens JJ, Hewitt A, Schrum J, Schulz AS, Müller I, Stein J, Wynn R, Greil J, Sykora KW, Matthes-Martin S, Führer M, O’Meara A, Toporski J, Sedlacek P, Schlegel PG, Ehlert K, Fasth A, Winiarski J, Arvidson J, Mauz-Körholz C, Ozsahin H, Schrauder A, Bader P, Massaro J, D’Agostino R, Hoyle M, Iacobelli M, Debatin KM, Peters C, Dini G. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial. Lancet. 2012 Apr 7;379(9823):1301-9. doi: 10.1016/S0140-6736(11)61938-7. Epub 2012 Feb 23.
  • Elmariah S, Jang IK. Acute stent thrombosis: technical complication or inadequate antithrombotic therapy? An optical coherence tomography study. JACC Cardiovasc Interv. 2012 Feb;5(2):e3-4. doi: 10.1016/j.jcin.2011.09.026.
  • Armstrong EJ, Feldman DN, Wang TY, Kaltenbach LA, Yeo KK, Wong SC, Spertus J, Shaw RE, Minutello RM, Moussa I, Ho KK, Rogers JH, Shunk KA. Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis. JACC Cardiovasc Interv. 2012 Feb;5(2):131-40. doi: 10.1016/j.jcin.2011.10.013.
  • Weintraub WS, Grau-Sepulveda MV, Weiss JM, Delong ER, Peterson ED, O’Brien SM, Kolm P, Klein LW, Shaw RE, McKay C, Ritzenthaler LL, Popma JJ, Messenger JC, Shahian DM, Grover FL, Mayer JE, Garratt KN, Moussa ID, Edwards FH, Dangas GD. Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry. Circulation. 2012 Mar 27;125(12):1501-10. doi: 10.1161/CIRCULATIONAHA.111.066969. Epub 2012 Feb 23.
  • Yeh RW, Normand SL, Wang Y, Barr CD, Dominici F. Geographic disparities in the incidence and outcomes of hospitalized myocardial infarction: does a rising tide lift all boats?. Circ Cardiovasc Qual Outcomes. 2012 Mar 1;5(2):197-204. doi: 10.1161/CIRCOUTCOMES.111.962456. Epub 2012 Feb 21.
  • King G, Wood MJ. The right ventricle of the elite high end endurance athlete cannot be underestimated. J Am Soc Echocardiogr. 2012 Mar;25(3):272-3. doi: 10.1016/j.echo.2012.01.018.
  • Pencina MJ, D’Agostino RB Sr, Song L. Quantifying discrimination of Framingham risk functions with different survival C statistics. Stat Med. 2012 Jul 10;31(15):1543-53. doi: 10.1002/sim.4508. Epub 2012 Feb 17.
  • O’Seaghdha CM, Lyass A, Massaro JM, Meigs JB, Coresh J, D’Agostino RB Sr, Astor BC, Fox CS. A risk score for chronic kidney disease in the general population. Am J Med. 2012 Mar;125(3):270-7. doi: 10.1016/j.amjmed.2011.09.009.
  • Sampath J, Dietze DT, Toth PP, Cannon CP, Breslan SA. Are continuing medical education activities effective in improving the competence and performance of clinicians? Evidence from activities for primary care clinicians who manage patients with acute coronary syndromes. Crit Pathw Cardiol. 2012 Mar;11(1):1-9. doi: 10.1097/HPC.0b013e318242e6cd.
  • Bauer LK, Caro MA, Beach SR, Mastromauro CA, Lenihan E, Januzzi JL, Huffman JC. Effects of depression and anxiety improvement on adherence to medication and health behaviors in recently hospitalized cardiac patients. Am J Cardiol. 2012 May 1;109(9):1266-71. doi: 10.1016/j.amjcard.2011.12.017. Epub 2012 Feb 9.
  • Kapuku GK, Davis HC, Thomas P, Januzzi J, Harshfield GA. Does the relationship between natriuretic hormones and diastolic function differ by race?. Am J Med Sci. 2012 Aug;344(2):96-9. doi: 10.1097/MAJ.0b013e31823673fd.
  • Reynolds MR, Magnuson EA, Wang K, Lei Y, Vilain K, Walczak J, Kodali SK, Lasala JM, O’Neill WW, Davidson CJ, Smith CR, Leon MB, Cohen DJ; PARTNER Investigators. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation. 2012 Mar 6;125(9):1102-9. doi: 10.1161/CIRCULATIONAHA.111.054072. Epub 2012 Feb 3.
  • White HD, Chew DP, Dauerman HL, Mahaffey KW, Gibson CM, Stone GW, Gruberg L, Harrington RA, Bhatt DL. Reduced immediate ischemic events with cangrelor in PCI: a pooled analysis of the CHAMPION trials using the universal definition of myocardial infarction. Am Heart J. 2012 Feb;163(2):182-90.e4. doi: 10.1016/j.ahj.2011.11.001.
  • Cutlip DE. Evidence of safety and effectiveness for a drug-eluting stent: how should we respond this time?. Circulation. 2012 Mar 6;125(9):1078-80. doi: 10.1161/CIRCULATIONAHA.111.090241. Epub 2012 Feb 1.
  • Wu Y, Wu H, Mueller C, Gibson CM, Murphy S, Shi Y, Xu G, Yang J. Baseline platelet count and clinical outcome in acute coronary syndrome. Circ J. 2012;76(3):704-11. doi: 10.1253/circj.cj-11-0707. Epub 2012 Jan 26.
  • Kramer DB, Buxton AE, Zimetbaum PJ. Time for a change–a new approach to ICD replacement. N Engl J Med. 2012 Jan 26;366(4):291-3. doi: 10.1056/NEJMp1111467.
  • Morrison F, Shubina M, Turchin A. Lifestyle counseling in routine care and long-term glucose, blood pressure, and cholesterol control in patients with diabetes. Diabetes Care. 2012 Feb;35(2):334-41. doi: 10.2337/dc11-1635.
  • Gallo CB, Cury SE, Pinto DS Jr, Migliari DA, Sugaya NN. Intraoral carcinosarcoma on the floor of the mouth mimicking a benign lesion. Int J Oral Maxillofac Surg. 2012 Aug;41(8):970-3. doi: 10.1016/j.ijom.2011.12.004. Epub 2012 Jan 21.
  • Goodman SG, Clare R, Pieper KS, Nicolau JC, Storey RF, Cantor WJ, Mahaffey KW, Angiolillo DJ, Husted S, Cannon CP, James SK, Kilhamn J, Steg PG, Harrington RA, Wallentin L; Platelet Inhibition and Patient Outcomes Trial Investigators. Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial. Circulation. 2012 Feb 28;125(8):978-86. doi: 10.1161/CIRCULATIONAHA.111.032912. Epub 2012 Jan 18.
  • Franz RW, Willette PA, Wood MJ, Wright ML, Hartman JF. A systematic review and meta-analysis of diagnostic screening criteria for blunt cerebrovascular injuries. J Am Coll Surg. 2012 Mar;214(3):313-27. doi: 10.1016/j.jamcollsurg.2011.11.012. Epub 2012 Jan 11.
  • Lopes RD, Mehta RH, Hafley GE, Williams JB, Mack MJ, Peterson ED, Allen KB, Harrington RA, Gibson CM, Califf RM, Kouchoukos NT, Ferguson TB Jr, Alexander JH; Project of Ex Vivo Vein Graft Engineering via Transfection IV (PREVENT IV) Investigators. Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery. Circulation. 2012 Feb 14;125(6):749-56. doi: 10.1161/CIRCULATIONAHA.111.040311. Epub 2012 Jan 11.
  • Qian F, Ling FS, Deedwania P, Hernandez AF, Fonarow GC, Cannon CP, Peterson ED, Peacock WF, Kaltenbach LA, Laskey WK, Schwamm LH, Bhatt DL; Get With The Guidelines Steering Committee and Investigators. Care and outcomes of Asian-American acute myocardial infarction patients: findings from the American Heart Association Get With The Guidelines-Coronary Artery Disease program. Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):126-33. doi: 10.1161/CIRCOUTCOMES.111.961987. Epub 2012 Jan 10.
  • Pinto DS, Ogbonnaya A, Sherman SA, Tung P, Normand SL. Bivalirudin therapy is associated with improved clinical and economic outcomes in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention: results from an observational database. Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):52-61. doi: 10.1161/CIRCOUTCOMES.111.961938. Epub 2012 Jan 10.
  • Thanassoulis G, Peloso GM, Pencina MJ, Hoffmann U, Fox CS, Cupples LA, Levy D, D’Agostino RB, Hwang SJ, O’Donnell CJ. A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study. Circ Cardiovasc Genet. 2012 Feb 1;5(1):113-21. doi: 10.1161/CIRCGENETICS.111.961342. Epub 2012 Jan 10.
  • Celano CM, Mastromauro CA, Lenihan EC, Januzzi JL, Rollman BL, Huffman JC. Association of baseline anxiety with depression persistence at 6 months in patients with acute cardiac illness. Psychosom Med. 2012 Jan;74(1):93-9. doi: 10.1097/PSY.0b013e31823d38bc. Epub 2011 Dec 30.
  • Poh KK, Lee LC, Shen L, Chong E, Tan YL, Chai P, Yeo TC, Wood MJ. Left ventricular fluid dynamics in heart failure: echocardiographic measurement and utilities of vortex formation time. Eur Heart J Cardiovasc Imaging. 2012 May;13(5):385-93. doi: 10.1093/ejechocard/jer288. Epub 2011 Dec 16.
  • Prushik SG, Farber A, Gona P, Shrader P, Pencina MJ, D’Agostino RB Sr, Murabito JM. Parental intermittent claudication as risk factor for claudication in adults. Am J Cardiol. 2012 Mar 1;109(5):736-41. doi: 10.1016/j.amjcard.2011.10.032. Epub 2011 Dec 10.
  • Rastogi P, Pinto DS, Pai MR, Kanchan T. An autopsy study of coronary atherosclerosis and its relation to anthropometric measurements/indices of overweight and obesity in men. J Forensic Leg Med. 2012 Jan;19(1):12-7. doi: 10.1016/j.jflm.2011.09.003. Epub 2011 Oct 7.
  • Pencina MJ, D’Agostino RB Sr, Demler OV. Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models. Stat Med. 2012 Jan 30;31(2):101-13. doi: 10.1002/sim.4348. Epub 2011 Dec 7.
  • Appelbaum E, Maron BJ, Adabag S, Hauser TH, Lesser JR, Haas TS, Riley AB, Harrigan CJ, Delling FN, Udelson JE, Gibson CM, Manning WJ, Maron MS. Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. 2012 Jan;5(1):78-85. doi: 10.1161/CIRCIMAGING.111.963819. Epub 2011 Dec 1.
  • Isik T, Uyarel H, Tanboga IH, Kurt M, Ekinci M, Kaya A, Ayhan E, Ergelen M, Bayram E, Gibson CM. Relation of red cell distribution width with the presence, severity, and complexity of coronary artery disease. Coron Artery Dis. 2012 Jan;23(1):51-6. doi: 10.1097/MCA.0b013e32834e4f5c.
  • Grandin EW, Jarolim P, Murphy SA, Ritterova L, Cannon CP, Braunwald E, Morrow DA. Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22. Clin Chem. 2012 Jan;58(1):267-73. doi: 10.1373/clinchem.2011.174359. Epub 2011 Nov 22.
  • Fleming LM, Novack V, Novack L, Cohen SA, Negoita M, Cutlip DE. Frequency and impact of bleeding in elective coronary stent clinical trials–utility of three commonly used definitions. Catheter Cardiovasc Interv. 2012 Aug 1;80(2):E23-9. doi: 10.1002/ccd.23332. Epub 2012 Jan 10.
  • Patel SJ, Tapper EB, Cutlip DE. Clinical pearls regarding Prinzmetal’s angina complicated by cardiac arrest–management during therapeutic hypothermia. Int J Cardiol. 2012 Aug 9;159(1):55-7. doi: 10.1016/j.ijcard.2011.10.122. Epub 2011 Nov 21.
  • Kaya MG, Uyarel H, Akpek M, Kalay N, Ergelen M, Ayhan E, Isik T, Cicek G, Elcik D, Sahin O, Cosgun SM, Oguzhan A, Eren M, Gibson CM. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol. 2012 Feb 15;109(4):486-91. doi: 10.1016/j.amjcard.2011.09.042. Epub 2011 Nov 17.
  • Murphy TP, Dhangana R, Pencina MJ, D’Agostino RB Sr. Ankle-brachial index and cardiovascular risk prediction: an analysis of 11,594 individuals with 10-year follow-up. Atherosclerosis. 2012 Jan;220(1):160-7. doi: 10.1016/j.atherosclerosis.2011.10.037. Epub 2011 Nov 3.
  • Triant VA, Josephson F, Rochester CG, Althoff KN, Marcus K, Munk R, Cooper C, D’Agostino RB, Costagliola D, Sabin CA, Williams PL, Hughes S, Post WS, Chandra-Strobos N, Guaraldi G, Young SS, Obenchain R, Bedimo R, Miller V, Strobos J. Adverse outcome analyses of observational data: assessing cardiovascular risk in HIV disease. Clin Infect Dis. 2012 Feb 1;54(3):408-13. doi: 10.1093/cid/cir829. Epub 2011 Nov 17.
  • Murphy TP, Cutlip DE, Regensteiner JG, Mohler ER, Cohen DJ, Reynolds MR, Massaro JM, Lewis BA, Cerezo J, Oldenburg NC, Thum CC, Goldberg S, Jaff MR, Steffes MW, Comerota AJ, Ehrman J, Treat-Jacobson D, Walsh ME, Collins T, Badenhop DT, Bronas U, Hirsch AT; CLEVER Study Investigators. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation. 2012 Jan 3;125(1):130-9. doi: 10.1161/CIRCULATIONAHA.111.075770. Epub 2011 Nov 16.
  • Pojoga LH, Coutinho P, Rivera A, Yao TM, Maldonado ER, Youte R, Adler GK, Williams J, Turchin A, Williams GH, Romero JR. Activation of the mineralocorticoid receptor increases striatin levels. Am J Hypertens. 2012 Feb;25(2):243-9. doi: 10.1038/ajh.2011.197. Epub 2011 Nov 17.
  • van Kimmenade RR, Januzzi JL Jr. Emerging biomarkers in heart failure. Clin Chem. 2012 Jan;58(1):127-38. doi: 10.1373/clinchem.2011.165720. Epub 2011 Nov 15.
  • Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM; ATLAS ACS 2–TIMI 51 Investigators. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med. 2012 Jan 5;366(1):9-19. doi: 10.1056/NEJMoa1112277. Epub 2011 Nov 13.
  • Sam S, Haffner S, Davidson MH, D’Agostino R Sr, Perez A, Mazzone T. Pioglitazone-mediated changes in lipoprotein particle composition are predicted by changes in adiponectin level in type 2 diabetes. J Clin Endocrinol Metab. 2012 Jan;97(1):E110-4. doi: 10.1210/jc.2011-1699. Epub 2011 Nov 9.
  • Ueland T, Smedbakken LM, Hallén J, Atar D, Januzzi JL, Halvorsen B, Jensen JK, Aukrust P. Soluble CXCL16 and long-term outcome in acute ischemic stroke. Atherosclerosis. 2012 Jan;220(1):244-9. doi: 10.1016/j.atherosclerosis.2011.10.004. Epub 2011 Oct 12.
  • Reid KF, Doros G, Clark DJ, Patten C, Carabello RJ, Cloutier GJ, Phillips EM, Krivickas LS, Frontera WR, Fielding RA. Muscle power failure in mobility-limited older adults: preserved single fiber function despite lower whole muscle size, quality and rate of neuromuscular activation. Eur J Appl Physiol. 2012 Jun;112(6):2289-301. doi: 10.1007/s00421-011-2200-0. Epub 2011 Oct 18.
  • Bainey KR, Selzer F, Cohen HA, Marroquin OC, Holper EM, Graham MM, Williams DO, Faxon DP. Comparison of three age groups regarding safety and efficacy of drug-eluting stents (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol. 2012 Jan 15;109(2):195-201. doi: 10.1016/j.amjcard.2011.08.028. Epub 2011 Oct 14.
  • Kimokoti RW, Newby PK, Gona P, Zhu L, Campbell WR, D’Agostino RB, Millen BE. Stability of the Framingham Nutritional Risk Score and its component nutrients over 8 years: the Framingham Nutrition Studies. Eur J Clin Nutr. 2012 Mar;66(3):336-44. doi: 10.1038/ejcn.2011.167. Epub 2011 Oct 5.
  • Suzuki T, Isselbacher EM, Nienaber CA, Pyeritz RE, Eagle KA, Tsai TT, Cooper JV, Januzzi JL Jr, Braverman AC, Montgomery DG, Fattori R, Pape L, Harris KM, Booher A, Oh JK, Peterson M, Ramanath VS, Froehlich JB; IRAD Investigators. Type-selective benefits of medications in treatment of acute aortic dissection (from the International Registry of Acute Aortic Dissection [IRAD]). Am J Cardiol. 2012 Jan 1;109(1):122-7. doi: 10.1016/j.amjcard.2011.08.012. Epub 2011 Sep 23.
  • Chakrabarti AK, Gibson CM. Short- and long-term treatment with non-steroidal anti-inflammatory drugs increases risk of death or recurrent MI in those with previous MI. Evid Based Med. 2012 Apr;17(2):61-2. doi: 10.1136/ebm.2011.100132. Epub 2011 Sep 21.
  • Wang W, Wykrzykowska JJ, Pinto DS. Covered stent implantation for giant saphenous vein graft pseudoaneurysms. Int J Cardiol. 2012 May 3;156(3):e65-7. doi: 10.1016/j.ijcard.2011.08.065. Epub 2011 Sep 16.
  • Soubry A, Il’yasova D, Sedjo R, Wang F, Byers T, Rosen C, Yashin A, Ukraintseva S, Haffner S, D’Agostino R Jr. Increase in circulating levels of IGF-1 and IGF-1/IGFBP-3 molar ratio over a decade is associated with colorectal adenomatous polyps. Int J Cancer. 2012 Jul 15;131(2):512-7. doi: 10.1002/ijc.26393. Epub 2011 Sep 14.
  • Kramer DB, Friedman PA, Kallinen LM, Morrison TB, Crusan DJ, Hodge DO, Reynolds MR, Hauser RG. Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators. Heart Rhythm. 2012 Jan;9(1):42-6. doi: 10.1016/j.hrthm.2011.08.031. Epub 2011 Sep 3.
  • Krum H, Swergold G, Gammaitoni A, Peloso PM, Smugar SS, Curtis SP, Brater DC, Wang H, Kaur A, Laine L, Weir MR, Cannon CP. Blood pressure and cardiovascular outcomes in patients taking nonsteroidal antiinflammatory drugs. Cardiovasc Ther. 2012 Dec;30(6):342-50. doi: 10.1111/j.1755-5922.2011.00283.x. Epub 2011 May 25.
  • Burgers WA, Manrique A, Masopust D, McKinnon LR, Reynolds MR, Rolland M, Blish C, Chege GK, Curran R, Fischer W, Herrera C, Sather DN. Measurements of immune responses for establishing correlates of vaccine protection against HIV. AIDS Res Hum Retroviruses. 2012 Jul;28(7):641-8. doi: 10.1089/AID.2011.0239. Epub 2011 Sep 23.
  • Ladapo JA, David G, Gunnarsson CL, Hao SC, White SA, March JL, Reynolds MR. Healthcare utilization and expenditures in patients with atrial fibrillation treated with catheter ablation. J Cardiovasc Electrophysiol. 2012 Jan;23(1):1-8. doi: 10.1111/j.1540-8167.2011.02130.x. Epub 2011 Jul 21.
  • Farber A, Tan TW, Hamburg NM, Kalish JA, Joglar F, Onigman T, Rybin D, Doros G, Eberhardt RT. Early fasciotomy in patients with extremity vascular injury is associated with decreased risk of adverse limb outcomes: a review of the National Trauma Data Bank. Injury. 2012 Sep;43(9):1486-91. doi: 10.1016/j.injury.2011.06.006. Epub 2011 Jun 29.
  • Gray WA, Yeung AC, Cutlip DE, Popma JJ, Fitzgerald PJ, Williams DO, Heuer H, O’Shaughnessy CD, Overlie PA, Mann JT, Cannon LA, Hermiller JB, Henry TD, Whitbourn R, Stuckey TD, Midei MG, Coe J, Schwartz LB. A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: final results of the ZoMaxx II trial. Int J Cardiol. 2012 May 17;157(1):96-101. doi: 10.1016/j.ijcard.2011.05.061. Epub 2011 Jun 11.
  • Pascual-Figal DA, Bonaque JC, Manzano-Fernández S, Fernández A, Garrido IP, Pastor-Perez F, Lax A, Valdes M, Januzzi JL. Red blood cell distribution width predicts new-onset anemia in heart failure patients. Int J Cardiol. 2012 Oct 18;160(3):196-200. doi: 10.1016/j.ijcard.2011.04.018. Epub 2011 May 8.
  • Jensen JK, Medina HM, Nørgaard BL, Øvrehus KA, Jensen JM, Nielsen LH, Maurovich-Horvat P, Engel LC, Januzzi JL, Hoffmann U, Truong QA. Association of ischemic stroke to coronary artery disease using computed tomography coronary angiography. Int J Cardiol. 2012 Oct 18;160(3):171-4. doi: 10.1016/j.ijcard.2011.04.006. Epub 2011 May 4.
  • Cohen DJ, Lavelle TA, Van Hout B, Li H, Lei Y, Robertus K, Pinto D, Magnuson EA, Mcgarry TF, Lucas SK, Horwitz PA, Henry CA, Serruys PW, Mohr FW, Kappetein AP. Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial. Catheter Cardiovasc Interv. 2012 Feb 1;79(2):198-209. doi: 10.1002/ccd.23147. Epub 2011 Sep 26.
  • Kırma C, Erkol A, Pala S, Oduncu V, Dündar C, İzgi A, Tigen K, Gibson CM. Intracoronary bolus-only compared with intravenous bolus plus infusion of tirofiban application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Catheter Cardiovasc Interv. 2012 Jan 1;79(1):59-67. doi: 10.1002/ccd.23109. Epub 2011 Nov 30.
  • Bamberg F, Truong QA, Koenig W, Schlett CL, Nasir K, Butler J, Kurtz E, Nikolaou K, Hoffmann U, Januzzi JL Jr. Differential associations between blood biomarkers of inflammation, oxidation, and lipid metabolism with varying forms of coronary atherosclerotic plaque as quantified by coronary CT angiography. Int J Cardiovasc Imaging. 2012 Jan;28(1):183-92. doi: 10.1007/s10554-010-9773-2. Epub 2011 Jan 9.
  • Kunadian V, Gibson CM. Thrombolytics and myocardial infarction. Cardiovasc Ther. 2012 Apr;30(2):e81-8. doi: 10.1111/j.1755-5922.2010.00239.x. Epub 2010 Nov 11.